Medivir Presents at the Rodman & Renshaw Conference

Medivir Presents at the Rodman & Renshaw Conference

Medivir has participated in, and was today presented before, the Acumen BioFin
Rodman & Renshaw 5th Annual Healthcare Conference in Monaco. The presentation
provides an update on Medivir's projects, including the newly signed deal with
Tibotec on HCV polymerase inhibitors.

The presentation is now available on Medivir's website under the
Investor&Media/Latest events tab.


For additional information, please contact
Rein Piir, CFO & VP Investor Relations, Medivir +46 708 537 292.


For more on Medivir, please see the company website: www.medivir.se